Comparing Efficacy Between Two Protocols of Intravenous Insulin Infusion for Diabetic Adults in ICU
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age19+
SponsorSuez Canal University
About this trial
The goal of clinical trial is to improve the adequacy of blood sugar control in diabetic critically ill adult patients who admitted to the intensive care unit(ICU) in Suez Canal University (SCU) hospitals by comparing glycemic control efficacy between the NHS in the UK and suggested SCU Protocols of Intravenous Insulin Infusion.
The main questions it aims to answer are:
Is SCU protocol of Intravenous Insulin Infusion more effective than NHS protocol in achieving blood glucose control targets in critically ill adult patients?
Researchers will compare glycemic control efficacy between the NHS in UK and suggested SCU Protocols of Intravenous Insulin Infusion for critically ill Adults in ICU to determine the best protocol in achieving good blood glucose control in diabetic critically ill adult patients in SCU Hospitals.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patients who admitted to the hospital with a potentially life-threatening condition (Critically ill patients) with HbA1C >6.0.
Disqualifiers
DKA patients.
Pregnant or breast-feeding patients.
Hyperosmolar Non-Ketotic Coma.
Trial design
Design model
Parallel
Treatments tested in this trial
Insulin infusion protocol
Procedure/Surgerycomparing the efficacy of 2 different protocols for glycemic control in diabetic critically ill patients.
Treatment groups
100 Participants
are divided into 2 treatment groupsGroup A: Suez Canal University variable rate ProtocolActive comparator 1 intervention
Group B: NHS groupActive comparator 1 intervention
Trial outcomes
Primary outcomes
1
Time needed to achieve the target blood glucose (80-180)
Assess the time needed to achieve the target blood glucose (80-180) in both protocols of intravenous insulin infusion in management of hyperglycemia in diabetic critically ill patients.
Time frame
up to 28 daysSecondary outcomes
1
Assess the effect of different factors in the management of hyperglycemia in critical ill patients.
Assess the effect of different factors in the management of hyperglycemia in critical ill patients (age, gender comorbidities, etc.)
Time frame
up to 28 days2
Assess the incidence of hypoglycemia among the patients of both groups.
Assess the incidence of hypoglycemia among the patients of both groups.
Time frame
up to 28 days3
Compare Ventilator Free Days between two groups.
Compare Ventilator Free Days between two groups
Time frame
up to 28 days4
Compare the ICU stay and hospital stay between the two groups.
Compare the ICU stay and hospital stay between the two groups.
Time frame
up to 28 daysSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov